# Pyxis Oncology, Inc.: Form 8-K, filed Jul 3, 2025

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: 8-K
- Filed: 2025-07-03
- Accepted by EDGAR: Jul 2, 2025, 20:30 ET
- Period: 2025-07-01
- Accession: 0000950170-25-093456
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/pyxs-20250701.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/pyxs-20250701.htm

Filed Jul 3, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-093456. Last ingested by Listed: Nov 6, 2026, 18:47 ET. No prices; not investment advice.